GlassScriptPhysician profile
Michael P Eyre
NPI 1063481646
$8,970.70
in general payments reported to CMS, 2019-2025
34 companies · $1,168 in 2025
The $1,168 reported for 2025 was more than what 77% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $1,067 · 2021: $1,323 · 2022: $1,246 · 2023: $1,184 · 2024: $1,593 · 2025: $1,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,846 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,845.87 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,959.62 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $760.21 | 2019-2025 | Ilumya |
| Novartis Pharmaceuticals Corporation | $728.80 | 2019-2025 | |
| Janssen Biotech, INC. | $635.80 | 2019-2024 | Tremfya, Simponi Aria, Simponi |
| Ucb, INC. | $566.41 | 2019-2025 | Bimzelx, Cimzia |
| Prugen, INC. Pharmaceuticals | $554.93 | 2019-2020 | |
| Lilly USA, LLC | $548.74 | 2019-2025 | Ebglyss, Taltz, Olumiant |
| Pfizer INC. | $471.78 | 2019-2025 | |
| Dermavant Sciences, INC. | $407.98 | 2022-2024 | Vtama |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $312.11 | 2019-2025 | Cabtreo, Jublia |
| Galderma Laboratories, L.P. | $300.31 | 2019-2024 | Aklief |
| E.R. Squibb & Sons, L.L.C. | $265.81 | 2022-2025 | Sotyktu |
| Genzyme Corporation | $210.95 | 2019-2025 | |
| Leo Pharma INC. | $190.96 | 2023-2025 | Adbry, Anzupgo |
| Vyne Pharmaceuticals INC. | $177.11 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $142.57 | 2019-2025 | Otezla, Otezla |
| Genentech USA, INC. | $135.46 | 2019-2022 | |
| Organon LLC | $113.84 | 2025 | Vtama |
| Regeneron Healthcare Solutions, INC. | $91.86 | 2021-2024 | Libtayo, Dupixent |
| Boston Scientific Corporation | $66.40 | 2023 | |
| Biofrontera INC. | $43.39 | 2019-2023 | Ameluz, Xepi, Bf-Rhodoled |
| Epi Health, LLC | $36.56 | 2019 | |
| Dermira, INC. | $32.42 | 2019 | |
| Kyowa Kirin, INC. | $27.83 | 2024 | Poteligeo |
| Mylan Pharmaceuticals INC. | $26.06 | 2019 | |
| Mission Pharmacal Company | $21.93 | 2021 | |
| Encore Dermatology INC. | $21.14 | 2019 | |
| Smith+Nephew, INC. | $21.14 | 2025 | Grafix Pl |
| Journey Medical Corporation | $20.82 | 2025 | |
| Incyte Corporation | $19.08 | 2021 | |
| Arcutis Biotherapeutics, INC. | $17.27 | 2023 | |
| Botanix Sb INC | $15.71 | 2025 | Sofdra |
| Merck Sharp & Dohme LLC | $14.58 | 2019 | |
| Dusa Pharmaceuticals, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Eyre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.